His main research concerns Immunology, Inflammation, Internal medicine, Innate immune system and Endocrinology. His work deals with themes such as Macrophage and Lung, which intersect with Immunology. His Inflammation research incorporates themes from Eosinophil, Bronchoalveolar lavage and p38 mitogen-activated protein kinases.
His studies deal with areas such as Airway and Pathology as well as Internal medicine. His Innate immune system study integrates concerns from other disciplines, such as Immunity and Monocyte. Gary P. Anderson has researched Endocrinology in several fields, including Orexigenic and Receptor.
His primary areas of investigation include Immunology, Inflammation, Internal medicine, Lung and COPD. His research in Immunology intersects with topics in Macrophage and Respiratory system. His Inflammation research includes elements of Bronchoalveolar lavage, Cancer research and Innate immune system.
His Internal medicine study frequently intersects with other fields, such as Endocrinology. His COPD research incorporates elements of Pulmonary disease and Exacerbation. His work deals with themes such as Disease, Allergy and Intensive care medicine, which intersect with Asthma.
Gary P. Anderson mostly deals with Immunology, COPD, Breathing, Asthma and Respiratory system. His Lung research extends to Immunology, which is thematically connected. His studies deal with areas such as Spirometry, Disease and Incidence as well as COPD.
His Asthma research includes themes of Observational study and Intensive care medicine. He has included themes like Interleukin 6 and Inflammatory lung disease in his Respiratory system study. His Inflammation study combines topics in areas such as Cancer, Macrophage and Immune system.
His scientific interests lie mostly in Immunology, Inflammation, Asthma, COPD and MEDLINE. His Immunology research incorporates elements of Macrophage, Obstructive lung disease and Lung. His Inflammation study combines topics from a wide range of disciplines, such as Cancer, Cytokine and Immune system.
The Asthma study which covers Clinical research that intersects with Patient centred, Intersectoral Collaboration, Asthma therapy and Airway inflammation. His COPD research integrates issues from Incidence, Prospective cohort study, Disease, Physical therapy and Systemic inflammation. Gary P. Anderson interconnects Exhaled nitric oxide, Respiration Disorders, Public health and Intensive care medicine in the investigation of issues within MEDLINE.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease
Gary P Anderson.
The Lancet (2008)
How cigarette smoke skews immune responses to promote infection, lung disease and cancer
Martin R. Stämpfli;Gary P. Anderson.
Nature Reviews Immunology (2009)
Interleukin-4 is required for the induction of lung Th2 mucosal immunity.
A J Coyle;G Le Gros;C Bertrand;S Tsuyuki.
American Journal of Respiratory Cell and Molecular Biology (1995)
After asthma: redefining airways diseases
Ian D Pavord;Richard Beasley;Alvar Agusti;Gary P Anderson.
The Lancet (2017)
A protective role for protease-activated receptors in the airways
T. M. Cocks;B. Fong;J. M. Chow;G. P. Anderson.
Severe asthma in adults: what are the important questions?
Pascal Chanez;Sally E. Wenzel;Gary P. Anderson;Josep M. Anto.
The Journal of Allergy and Clinical Immunology (2007)
Interaction between glucocorticoids and β2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling
Michael Roth;Michael Roth;Peter R A Johnson;Jochen J Rüdiger;Gregory G King.
The Lancet (2002)
Neutrophils, interleukin-17A and lung disease.
A. Lindén;M. Laan;G. P. Anderson.
European Respiratory Journal (2005)
Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease.
Steven Bozinovski;Anastasia Hutchinson;Michelle Thompson;Lochlan MacGregor.
American Journal of Respiratory and Critical Care Medicine (2008)
Why are long-acting beta-adrenoceptor agonists long-acting?
Anderson Gp;Lindén A;Rabe Kf.
European Respiratory Journal (1994)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking d-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: